Skip to content

Ayurvedic Management on Memory Impairment

A Comparative Clinical Study on the effect of Vriddhadaruka Rasayan and Goghrita on enhancement of Smriti w.s.r to Memory Impairment.

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/05/019372
Enrollment
60
Registered
2019-05-27
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R298- Other symptoms and signs involvingthe nervous and musculoskeletal systems

Interventions

Intervention1: Vriddhadaruka Rasayan: Vriddhadaruka Rasayan 5gm twice a day for 2 months Control Intervention1: Goghrita: Goghrita 10ml twice a day for 2 months

Sponsors

All India Institute of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients between 41-60 years of age. Gender: both Socio-economic status: any Healthy volunteers willing to participate in the trial and diagnosed to have impaired memory as per the memory scale. Complaints of memory impairment on the basis of short term and long term. Short term, e.g. misplacing objects, difficulty in remembering multiple items to be purchased, difficulty in recalling information quickly, problems in remembering names and telephone numbers. Long term, e.g. difficulty in recall of special events of personal life, difficulty in recall of previous histories of life and recognition. Mini Mental State Examination. Hamilton anxiety scale criteria.

Exclusion criteria

Exclusion criteria: Patients not willing to participate in the clinical trial. History of any surgical intervention to brain. Intake of over the counter memory enhancing drugs in the previous 6 months. Any type of psychosis Dementia due to brain injury. Patients with evidence of delirium, confusion or other disturbances of consciousness, Parkinsonâ??s disease, stroke, intracranial haemorrhage, brain tumours, history of alcoholism or drug dependence, use of any psychotropic drug, Alzheimerâ??s disease, diabetes mellitus, endocrinal dysfunction. Patients with evidence of malignancy. Patients suffering from major systemic illness necessitating long term drug treatment (Rheumatoid arthritis, Tuberculosis, Psycho-neuro-endocrinal disorders etc) Patients who have completed participation in any other clinical trial during the past six months. Any other condition which the Principal Investigator thinks may jeopardize the study.

Design outcomes

Primary

MeasureTime frame
Effect on memory enhancementTimepoint: Assesment will be made on 1st day,16th day,31st day,46th day and 61st day including 1 month follow up with fortnightly visit.

Secondary

MeasureTime frame
Change in quality of life-SF 36 ScaleTimepoint: Assesment will be made on 1st day,16th day,31st day,46th day and 61st day including 1 month follow up with fortnightly visit.

Countries

India

Contacts

Public ContactDr VG Huddar

All India Institute of Ayurveda

drrky68@gmail.com9412148437

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026